63
Mycobacterium Dr. J Sheehama UNAM School of Medicine

Mycobacterium (1)

Embed Size (px)

Citation preview

Page 1: Mycobacterium (1)

Mycobacterium

Dr. J Sheehama

UNAM School of Medicine

Page 2: Mycobacterium (1)

Tuberculosis is a

leading cause of death

worldwide (~1.4

million)*

Namibia

Population: 2.1 million

In 2009: TB case

notification rate of 634

per 100 000**

In 2010: TB case

notification rate of 589

per 100 000

*WHO

** MoHSS

Introduction and background

Page 3: Mycobacterium (1)

• Pulmonary TB is caused by Mycobacterium tuberculosis

– Lung is the prime target for infections

• TB is one of the opportunistic infections in HIV-AIDS patients

Introduction and background information

Page 4: Mycobacterium (1)

Introduction and background

• Transmission of TB

Page 5: Mycobacterium (1)

Mycobacterium tuberculosis

Mycobacterium leprae (uncommon)

Mycobacterium avium-intracellulaire Complex

(MAC) or (M. avium)

Important Human Pathogens

Page 6: Mycobacterium (1)

Lipid-Rich Cell Wall of Mycobacterium Mycolic acids

CMN Group: Unusual cell wall

lipids (mycolic

acids,etc.)

(Purified Protein Derivative)

Page 7: Mycobacterium (1)

Acid-Fast (Kinyoun) Stain of

Mycobacterium

NOTE: cord growth (serpentine

arrangement) of virulent strains

Page 8: Mycobacterium (1)

Photochromogenic Mycobacterium

kansasii on Middlebrook Agar

NOTE: Mycobacteria pathogenic

for humans can be differentiated

(Runyon Groups) by:

speed of growth (all are

slower than most other

pathogens) and by

production of chromogenic

pigments (in light, in dark,

or none)

Page 9: Mycobacterium (1)

Improved Mycobacterial Isolation Medium

Page 10: Mycobacterium (1)

Eight Week Growth of

Mycobacterium tuberculosis on

Lowenstein-Jensen Agar

Page 11: Mycobacterium (1)

Pathogenic Mycobacterium spp.

BCG

AIDS

patients

Page 12: Mycobacterium (1)

Mycobacterial Clinical Syndromes

Page 13: Mycobacterium (1)

Diagram

of a

Granuloma

NOTE: ultimately a

fibrin layer develops

around granuloma

(fibrosis), further

“walling off” the

lesion.

Typical progression

in pulmonary TB

involves caseation,

calcification and

cavity formation.

Page 14: Mycobacterium (1)

Laboratory Diagnosis of

Mycobacterial Disease

Nucleic acid probes

Nucleic acid sequencing

Page 15: Mycobacterium (1)

Differential Characteristics of

Commonly Isolated

Mycobacterium spp.

Page 16: Mycobacterium (1)
Page 17: Mycobacterium (1)

Mycobacterium

tuberculosis

Page 18: Mycobacterium (1)

Mycobacterium

tuberculosis

Infections

Page 19: Mycobacterium (1)

Incidence of Tuberculosis in USA

Page 20: Mycobacterium (1)

Mycobacterium

tuberculosis

Infections (cont.)

BCG (bacille Calmette-Guerin)

= attenuated M. bovis

Positive PPD + Chest X-Ray +

MDR-TB a serious

global health threat

Page 21: Mycobacterium (1)

Pneumonia

Granuloma formation with fibrosis

Caseous necrosis • Tissue becomes dry & amorphous (resembling cheese)

• Mixture of protein & fat (assimilated very slowly)

Calcification • Ca++ salts deposited

Cavity formation • Center liquefies & empties into bronchi

Typical Progression of

Pulmonary Tuberculosis

Page 22: Mycobacterium (1)

PPD Tuberculosis Skin Test Criteria

PPD = Purified Protein Derivative from M. tuberculosis

Page 23: Mycobacterium (1)

Chest X-Ray of Patient with Active

Pulmonary Tuberculosis

Page 24: Mycobacterium (1)

Mycobacterium Tuberculosis

Stained with Fluorescent Dye

Page 25: Mycobacterium (1)
Page 26: Mycobacterium (1)

Mycobacterium leprae

Page 27: Mycobacterium (1)

Mycobacterium leprae Infections

Page 28: Mycobacterium (1)

Mycobacterium leprae Infections (cont.)

Page 29: Mycobacterium (1)

Tuberculoid vs. Lepromatous Leprosy Clinical Manifestations and Immunogenicity

Page 30: Mycobacterium (1)

Lepromatous vs. Tuberculoid Leprosy

Page 31: Mycobacterium (1)

Lepromatous Leprosy (Early/Late Stages)

Page 32: Mycobacterium (1)

Lepromatous Leprosy Pre-

and Post-Treatment

Page 33: Mycobacterium (1)

Clinical Progression of Leprosy

Page 34: Mycobacterium (1)

Effect of Cell-Mediated Immunity on

Leprosy Clinical Outcome

Page 35: Mycobacterium (1)
Page 36: Mycobacterium (1)

Mycobacterium avium-

intracellulaire Complex

(MAC)

Page 37: Mycobacterium (1)

Mycobacterium avium-intracellulaire Infections

Page 38: Mycobacterium (1)

Mycobacterium avium-intracellulaire Infections

Page 39: Mycobacterium (1)

M. avium-

intracellulaire

Complex (MAC)

Progression vs.

CD4 Count in

AIDS Patients

Page 40: Mycobacterium (1)

Mycobacterium avium-intracellulaire in

Tissue Specimens

Low Magnification High Magnification

Page 41: Mycobacterium (1)
Page 42: Mycobacterium (1)

REVIEW of

Mycobacterium

Page 43: Mycobacterium (1)

Mycobacterium tuberculosis

Mycobacterium leprae (uncommon)

Mycobacterium avium-intracellulaire Complex

(MAC) or (M. avium)

Important Human Pathogens

REVIEW

Page 44: Mycobacterium (1)

Lipid-Rich Cell Wall of Mycobacterium Mycolic acids

CMN Group: Unusual cell wall

lipids (mycolic

acids,etc.)

(Purified Protein Derivative)

REVIEW

Page 45: Mycobacterium (1)

Pathogenic Mycobacterium spp.

BCG

AIDS

patients

REVIEW

Page 46: Mycobacterium (1)

Mycobacterial Clinical Syndromes

REVIEW

Page 47: Mycobacterium (1)

Diagram

of a

Granuloma

NOTE: ultimately a

fibrin layer develops

around granuloma

(fibrosis), further

“walling off” the

lesion.

Typical progression

in pulmonary TB

involves caseation,

calcification and

cavity formation. REVIEW

Page 48: Mycobacterium (1)

Review of Mycobacterium

tuberculosis

Page 49: Mycobacterium (1)

Mycobacterium

tuberculosis

Infections

REVIEW

Page 50: Mycobacterium (1)

Mycobacterium

tuberculosis

Infections (cont.)

BCG (bacille Calmette-Guerin)

= attenuated M. bovis

Positive PPD + Chest X-Ray +

MDR-TB a serious

global health threat

REVIEW

Page 51: Mycobacterium (1)

Pneumonia

Granuloma formation with fibrosis

Caseous necrosis • Tissue becomes dry & amorphous (resembling cheese)

• Mixture of protein & fat (assimilated very slowly)

Calcification • Ca++ salts deposited

Cavity formation • Center liquefies & empties into bronchi

Typical Progression of

Pulmonary Tuberculosis

REVIEW

Page 52: Mycobacterium (1)

Review of Mycobacterium leprae

Page 53: Mycobacterium (1)

Mycobacterium leprae Infections

REVIEW

Page 54: Mycobacterium (1)

Mycobacterium leprae Infections (cont.)

REVIEW

Page 55: Mycobacterium (1)

Lepromatous vs. Tuberculoid Leprosy

REVIEW

Page 56: Mycobacterium (1)

Lepromatous Leprosy (Early/Late Stages)

REVIEW

Page 57: Mycobacterium (1)

Clinical Progression of Leprosy

REVIEW

Page 58: Mycobacterium (1)

Effect of Cell-Mediated Immunity on

Leprosy Clinical Outcome

REVIEW

Page 59: Mycobacterium (1)

Review of Mycobacterium avium-

intracellulaire Complex

(M. avium)

Page 60: Mycobacterium (1)

Mycobacterium avium-intracellulaire Infections

REVIEW

Page 61: Mycobacterium (1)

Mycobacterium avium-intracellulaire Infections

REVIEW

Page 62: Mycobacterium (1)

M. avium-

intracellulaire

Complex (MAC)

Progression vs.

CD4 Count in

AIDS Patients

REVIEW

Page 63: Mycobacterium (1)

Home work – Due

25/02/2015

– describe the risk factors

of TB infection in your

Region